Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.33 |
| ▸ | PPARA | Q07869 | 2/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | GCGR | P47871 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.30 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | PDE2A | O00408 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20911042 | 0.97 | DHODH (0.32) | PPARGPPARAGCGRDHODHADORA3 | |
| SCHEMBL20910992 | 0.93 | NR3C1 (0.35) | PPARGPPARAKIF11GCGRDHODH | |
| SCHEMBL20910722 | 0.93 | PPARG (0.35) | PPARGPPARAKIF11CYP1A2CYP3A4 | |
| SCHEMBL20910845 | 0.92 | PPARG (0.33) | PPARGPPARAKIF11DHODHADORA3 | |
| SCHEMBL20910990 | 0.92 | DHODH (0.34) | PPARGPPARAKIF11GCGRDHODH | |
| SCHEMBL20910988 | 0.92 | PPARG (0.35) | PPARGPPARAKIF11ABCG2NR3C1 | |
| SCHEMBL20910534 | 0.91 | KIF11 (0.33) | KIF11GCGRDHODHADORA3CYP1A2 | |
| SCHEMBL20910541 | 0.91 | KIF11 (0.34) | KIF11GCGRDHODHADORA3CYP1A2 | |
| SCHEMBL21090058 | 0.90 | DHODH (0.35) | GCGRDHODHADORA3CYP1A2CYP3A4 | |
| SCHEMBL20910724 | 0.90 | CYP1A2 (0.35) | PPARGPPARAKIF11DHODHCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10998504-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-05-04 | — | — | US | disclosed |
| US-20190115544-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10998504-B2 | Organic molecules for use in optoelectronic devices | OCIAD1, OCIAD2, POU2F1 | PPARG 651/4885PPARA 1252/4885KIF11 451/4885 |
| US-20190115544-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OCIAD1, OCIAD2, POU2F1 | PPARG 651/4885PPARA 1252/4885KIF11 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.